Market Research Report

Sweden In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
cover Published by GlobalData
Published Product code 229171
Content info Pages: 269
Price

Introduction

Abstract

Sweden In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Summary

GlobalData's new report, "Sweden In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture" provides key market data on the Sweden In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Immuno Chemistry, Infectious Immunology, Clinical Chemistry, Haematology, Microbiology Culture, Histology And Cytology and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Market size and company share data for In Vitro Diagnostics market categories - Immuno Chemistry, Infectious Immunology, Clinical Chemistry, Haematology, Microbiology Culture, Histology And Cytology and Genetic Testing.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
  • 2011 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the Sweden In Vitro Diagnostics market.
  • Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Ortho-Clinical Diagnostics Inc., Beckman Coulter, Inc. and others.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Sweden In Vitro Diagnostics competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

TOC

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 9
  • 1.2 List of Figures 13

2 Introduction 16

  • 2.1 What is This Report About? 16

3 In Vitro Diagnostics In Sweden 17

  • 3.1 In Vitro Diagnostics, Market Segmentation 17
  • 3.2 In Vitro Diagnostics, Sweden, Overall Revenue ($m), USD Constant, 2004-2018 18
  • 3.3 In Vitro Diagnostics Market, Sweden, Revenue Mix ($m), 2011 20
  • 3.4 In Vitro Diagnostics Market, Sweden, Category Contribution (%), 2011 21
  • 3.5 In Vitro Diagnostics, Sweden, Company Share (2010-2011) 28

4 Clinical Chemistry In Sweden 30

  • 4.1 Clinical Chemistry, Market Segmentation 30
  • 4.2 Clinical Chemistry Market, Sweden, Revenue Mix ($m), 2011 31
  • 4.3 Clinical Chemistry Market, Sweden, Segment Contribution (%), 2011 32
  • 4.4 Clinical Chemistry Overall Revenue, (2004-2018) 33
    • 4.4.1 Clinical Chemisty Analyzers, Revenue (2004-2018) 37
    • 4.4.2 Urine Analysis, Revenue (2004-2018) 41
  • 4.5 Clinical Chemistry Distribution Share (2010-2011) 45
  • 4.6 Clinical Chemistry, Sweden, Company Share (2010-2011) 46

5 Genetic Testing In Sweden 48

  • 5.1 Genetic Testing, Market Segmentation 48
  • 5.2 Genetic Testing Market, Sweden, Revenue Mix ($m), 2011 49
  • 5.3 Genetic Testing Market, Sweden, Segment Contribution (%), 2011 50
  • 5.4 Genetic Testing Overall Revenue, (2004-2018) 51
  • 5.5 Genetic Testing Distribution Share (2010-2011) 55
  • 5.6 Genetic Testing, Sweden, Company Share (2010-2011) 56

6 Haematology In Sweden 58

  • 6.1 Haematology Market, Market Segmentation 58
  • 6.2 Haematology Market, Sweden, Revenue Mix ($m), 2011 59
  • 6.3 Haematology Market, Sweden, Segment Contribution (%), 2011 60
  • 6.4 Haematology Overall Revenue, (2004-2018) 61
    • 6.4.1 Haematology Reagents, Revenue (2004-2018) 65
    • 6.4.2 Immunohaematology, Revenue (2004-2018) 69
    • 6.4.3 Haemostasis, Revenue (2004-2018) 73
    • 6.4.4 Haematology Rapid Tests, Revenue (2004-2018) 77
    • 6.4.5 Haematology Cell Counters, Revenue (2004-2018) 81
  • 6.5 Haematology Distribution Share (2010-2011) 85
  • 6.6 Haematology, Sweden, Company Share (2010-2011) 86

7 Histology And Cytology In Sweden 88

  • 7.1 Histology and Cytology Market, Market Segmentation 88
  • 7.2 Histology And Cytology Market, Sweden, Revenue Mix ($m), 2011 89
  • 7.3 Histology And Cytology Market, Sweden, Segment Contribution (%), 2011 90
  • 7.4 Histology And Cytology Overall Revenue, (2004-2018) 91
  • 7.5 Histology And Cytology Distribution Share (2010-2011) 95
  • 7.6 Histology And Cytology, Sweden, Company Share (2010-2011) 96

8 Immuno Chemistry In Sweden 98

  • 8.1 Immuno Chemistry Market, Sweden, Revenue Mix ($m), 2011 98
  • 8.2 Immuno Chemistry Market, Sweden, Segment Contribution (%), 2011 99
  • 8.3 Immuno Chemistry Overall Revenue, (2004-2018) 100
    • 8.3.1 Disease Specific Immunochemistry, Revenue (2004-2018) 104
    • 8.3.2 Drugs of Abuse / Toxicology, Revenue (2004-2018) 108
    • 8.3.3 Endocrinology Tests, Revenue (2004-2018) 112
    • 8.3.4 Immunochemistry Rapid Tests, Revenue (2004-2018) 116
    • 8.3.5 Therapeutic Drug Monitoring, Revenue (2004-2018) 120
    • 8.3.6 Immunochemistry Analyzers, Revenue (2004-2018) 124
  • 8.4 Immuno Chemistry Distribution Share (2010-2011) 128
  • 8.5 Immuno Chemistry, Sweden, Company Share (2010-2011) 129

9 Infectious Immunology In Sweden 131

  • 9.1 Infectious Immunology, Market Segmentation 131
  • 9.2 Infectious Immunology Market, Sweden, Revenue Mix ($m), 2011 132
  • 9.3 Infectious Immunology Market, Sweden, Segment Contribution (%), 2011 133
  • 9.4 Infectious Immunology Overall Revenue, (2004-2018) 134
    • 9.4.1 Infectious Immunology Rapid Tests, Revenue (2004-2018) 138
  • 9.5 Infectious Immunology Distribution Share (2010-2011) 142
  • 9.6 Infectious Immunology, Sweden, Company Share (2010-2011) 143

10 Microbiology Culture In Sweden 145

  • 10.1 Microbiology Culture, Market Segmentation 145
  • 10.2 Microbiology Culture Market, Sweden, Revenue Mix ($m), 2011 146
  • 10.3 Microbiology Culture Market, Sweden, Segment Contribution (%), 2011 147
  • 10.4 Microbiology Culture Overall Revenue, (2004-2018) 148
    • 10.4.1 Microbiology Analyzers, Revenue (2004-2018) 152
  • 10.5 Microbiology Culture Distribution Share (2010-2011) 156
  • 10.6 Microbiology Culture, Sweden, Company Share (2010-2011) 157

11 Overview of Key Companies in Sweden In Vitro Diagnostics Market 159

  • 11.1 F. Hoffmann-La Roche Ltd. 159
    • 11.1.1 Company Overview 159
    • 11.1.2 Share in the Sweden In Vitro Diagnostics Market 159
  • 11.2 Siemens Healthcare 160
    • 11.2.1 Company Overview 160
    • 11.2.2 Share in the Sweden In Vitro Diagnostics Market 160
  • 11.3 Abbott Laboratories 161
    • 11.3.1 Company Overview 161
    • 11.3.2 Share in the Sweden In Vitro Diagnostics Market 161
  • 11.4 bioMerieux S.A. 162
    • 11.4.1 Company Overview 162
    • 11.4.2 Share in the Sweden In Vitro Diagnostics Market 162
  • 11.5 Ortho-Clinical Diagnostics Inc. 163
    • 11.5.1 Company Overview 163
    • 11.5.2 Share in the Sweden In Vitro Diagnostics Market 163
  • 11.6 Beckman Coulter, Inc. 164
    • 11.6.1 Company Overview 164
    • 11.6.2 Share in the Sweden In Vitro Diagnostics Market 164
  • 11.7 Sysmex Corporation 165
    • 11.7.1 Company Overview 165
  • 11.8 Becton, Dickinson and Company 165
    • 11.8.1 Company Overview 165
  • 11.9 Bio-Rad Laboratories, Inc. 166
    • 11.9.1 Company Overview 166
  • 11.10 Qiagen N.V. 166
    • 11.10.1 Company Overview 166
  • 11.11 DiaSorin S.p.A 167
    • 11.11.1 Company Overview 167
  • 11.12 Horiba, Ltd. 167
    • 11.12.1 Company Overview 167
  • 11.13 Diagnostica Stago, Inc. 168
    • 11.13.1 Company Overview 168
  • 11.14 PerkinElmer, Inc. 168
    • 11.14.1 Company Overview 168
  • 11.15 Thermo Fisher Scientific Inc. 169
    • 11.15.1 Company Overview 169
  • 11.16 Gen-Probe Incorporated 169
    • 11.16.1 Company Overview 169
  • 11.17 Grifols, S.A. 170
    • 11.17.1 Company Overview 170
  • 11.18 Cellestis Limited 170
    • 11.18.1 Company Overview 170
  • 11.19 Immucor, Inc. 171
    • 11.19.1 Company Overview 171
  • 11.20 Danaher Corporation 171
    • 11.20.1 Company Overview 171
  • 11.21 Mindray Medical International Limited 172
    • 11.21.1 Company Overview 172
  • 11.22 Life Technologies Corporation 172
    • 11.22.1 Company Overview 172
  • 11.23 Phadia AB 173
    • 11.23.1 Company Overview 173

12 In Vitro Diagnostics Market Pipeline Products 174

  • 12.1 Clinical Chemisty Market Pipeline Products 174
  • 12.2 Immuno Chemistry Market Pipeline Products 178
  • 12.3 Haematology Market Pipeline Products 189
  • 12.4 Infectious Immunology Market Pipeline Products 191
  • 12.5 Microbiology Culture Market Pipeline Products 198
  • 12.6 Histology And Cytology Market Pipeline Products 199
  • 12.7 Genetic Testing Market Pipeline Products 200

13 Financial Deals Landscape 205

  • 13.1 Acquisition 205
    • 13.1.1 Trinity Biotech To Acquire Fiomi Diagnostics From Alfven & Didrikson For $13.1 Million 205
    • 13.1.2 Addtech Life Science Acquires Reagent And Instrument Firm, BioNordika Group 207
  • 13.2 Partnerships 208
    • 13.2.1 bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 208
    • 13.2.2 Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System 210
    • 13.2.3 Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 211
    • 13.2.4 BioDot Enters Into Co-Marketing Agreement With JOT Automation 212
    • 13.2.5 BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays 213
    • 13.2.6 Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test 214
    • 13.2.7 Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology 216
    • 13.2.8 Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 217
    • 13.2.9 CML HealthCare Enters Into Agreement With MaRS Innovation 218
    • 13.2.10 Akrivis Technologies Enters Into Co-Development Agreement With United States Biological 219
    • 13.2.11 Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test 220
    • 13.2.12 Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products 221
    • 13.2.13 GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina 222
    • 13.2.14 Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test 223
    • 13.2.15 SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor 224
    • 13.2.16 Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 225
    • 13.2.17 MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test 226
    • 13.2.18 NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus 228
    • 13.2.19 Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 230
    • 13.2.20 Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test 232
    • 13.2.21 One Lambda Enters Into Co-Marketing Agreement With CellTrend 233
    • 13.2.22 Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker 234
    • 13.2.23 Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 235
    • 13.2.24 Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel 236
    • 13.2.25 Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker 237
    • 13.2.26 Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology 238
    • 13.2.27 Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 239
    • 13.2.28 Opko Health Enters Into Licensing Agreement With International Health Technology For Prostate Cancer Biomarker Panel 240
    • 13.2.29 ZyGem Enters Into Co-Marketing Agreement With Tataa Biocenter 241
    • 13.2.30 Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit 242
    • 13.2.31 Denator Enters Into Co-Development Agreement With Erasmus And Amsterdam Medical For Cancer Biomarker Platform 243
    • 13.2.32 Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 244
    • 13.2.33 Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For Pressure Cycling Technology 245
    • 13.2.34 LipoScience Enters Into Licensing Agreement With Cleveland Clinic 247
    • 13.2.35 GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System 248
    • 13.2.36 NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers 249
    • 13.2.37 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 250
    • 13.2.38 Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay For Sepsis 251

14 Recent Developments 252

  • 14.1 Government and Public Interest 252
    • 14.1.1 May 07, 2012: Researchers Of University of Gothenburg Develops Biomarkers That Can Reveal IBS 252
  • 14.2 Product News 252
    • 14.2.1 Jun 08, 2012: Allenex: University of Miami Initiates Clinical Trial Of XM-ONE 252
    • 14.2.2 Mar 08, 2012: Hansa Medical Announces Issuance Of European Patent For Diagnostic Method HMD-301 253

15 Appendix 254

  • 15.1 Definitions of Markets Covered in the Report 255
    • 15.1.1 In Vitro Diagnostics 255
  • 15.2 Research Methodology 266
  • 15.3 Secondary Research 266
  • 15.4 Primary Research 267
  • 15.5 Models 267
  • 15.6 Forecasts 268
  • 15.7 Expert Panels 268
  • 15.8 GlobalData Consulting 268
  • 15.9 Currency Conversion 269
  • 15.10 Contact Us 269
  • 15.11 Disclaimer 269

List of Tables

1.1 List of Tables

  • Table 1: In Vitro Diagnostics, Sweden, Overall Revenue ($m), USD Constant, 2004-2018 19
  • Table 2: In Vitro Diagnostics Market, Sweden, Category Contribution (%), 2011 21
  • Table 3: In Vitro Diagnostics Market, Sweden, Cross-Category Analysis, 2004-2018 23
  • Table 4: In Vitro Diagnostics, Sweden, Overall Revenue ($m), USD Constant, Historic, 2004-2011 25
  • Table 5: In Vitro Diagnostics, Sweden, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 27
  • Table 6: In Vitro Diagnostics, Sweden, Company Share by Revenue ($m), USD Constant, 2010-2011 29
  • Table 7: Clinical Chemistry Market, Sweden, Segment Contribution (%), 2011 32
  • Table 8: Clinical Chemistry, Sweden, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 34
  • Table 9: Clinical Chemistry, Sweden, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 36
  • Table 10: Clinical Chemisty Analyzers, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 38
  • Table 11: Clinical Chemisty Analyzers, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 40
  • Table 12: Urine Analysis, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 42
  • Table 13: Urine Analysis, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 44
  • Table 14: Clinical Chemistry, Sweden, Distribution Share by Revenue ($m), USD Constant, 2010-2011 45
  • Table 15: Clinical Chemistry, Sweden, Company Share by Revenue ($m), USD Constant, 2010-2011 47
  • Table 16: Genetic Testing Market, Sweden, Segment Contribution (%), 2011 50
  • Table 17: Genetic Testing, Sweden, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 52
  • Table 18: Genetic Testing, Sweden, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 54
  • Table 19: Genetic Testing, Sweden, Distribution Share by Revenue ($m), USD Constant, 2010-2011 55
  • Table 20: Genetic Testing, Sweden, Company Share by Revenue ($m), USD Constant, 2010-2011 57
  • Table 21: Haematology Market, Sweden, Segment Contribution (%), 2011 60
  • Table 22: Haematology, Sweden, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 62
  • Table 23: Haematology, Sweden, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 64
  • Table 24: Haematology Reagents, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 66
  • Table 25: Haematology Reagents, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 68
  • Table 26: Immunohaematology, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 70
  • Table 27: Immunohaematology, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 72
  • Table 28: Haemostasis, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 74
  • Table 29: Haemostasis, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 76
  • Table 30: Haematology Rapid Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 78
  • Table 31: Haematology Rapid Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 80
  • Table 32: Haematology Cell Counters, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 82
  • Table 33: Haematology Cell Counters, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 84
  • Table 34: Haematology, Sweden, Distribution Share by Revenue ($m), USD Constant, 2010-2011 85
  • Table 35: Haematology, Sweden, Company Share by Revenue ($m), USD Constant, 2010-2011 87
  • Table 36: Histology And Cytology Market, Sweden, Segment Contribution (%), 2011 90
  • Table 37: Histology And Cytology, Sweden, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 92
  • Table 38: Histology And Cytology, Sweden, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 94
  • Table 39: Histology And Cytology, Sweden, Distribution Share by Revenue ($m), USD Constant, 2010-2011 95
  • Table 40: Histology And Cytology, Sweden, Company Share by Revenue ($m), USD Constant, 2010-2011 97
  • Table 41: Immuno Chemistry Market, Sweden, Segment Contribution (%), 2011 99
  • Table 42: Immuno Chemistry, Sweden, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 101
  • Table 43: Immuno Chemistry, Sweden, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 103
  • Table 44: Disease Specific Immunochemistry, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 105
  • Table 45: Disease Specific Immunochemistry, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 107
  • Table 46: Drugs of Abuse / Toxicology, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 109
  • Table 47: Drugs of Abuse / Toxicology, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 111
  • Table 48: Endocrinology Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 113
  • Table 49: Endocrinology Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 115
  • Table 50: Immunochemistry Rapid Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 117
  • Table 51: Immunochemistry Rapid Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 119
  • Table 52: Therapeutic Drug Monitoring, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 121
  • Table 53: Therapeutic Drug Monitoring, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 123
  • Table 54: Immunochemistry Analyzers, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 125
  • Table 55: Immunochemistry Analyzers, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 127
  • Table 56: Immuno Chemistry, Sweden, Distribution Share by Revenue ($m), USD Constant, 2010-2011 128
  • Table 57: Immuno Chemistry, Sweden, Company Share by Revenue ($m), USD Constant, 2010-2011 130
  • Table 58: Infectious Immunology Market, Sweden, Segment Contribution (%), 2011 133
  • Table 59: Infectious Immunology, Sweden, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 135
  • Table 60: Infectious Immunology, Sweden, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 137
  • Table 61: Infectious Immunology Rapid Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 139
  • Table 62: Infectious Immunology Rapid Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 141
  • Table 63: Infectious Immunology, Sweden, Distribution Share by Revenue ($m), USD Constant, 2010-2011 142
  • Table 64: Infectious Immunology, Sweden, Company Share by Revenue ($m), USD Constant, 2010-2011 144
  • Table 65: Microbiology Culture Market, Sweden, Segment Contribution (%), 2011 147
  • Table 66: Microbiology Culture, Sweden, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 149
  • Table 67: Microbiology Culture, Sweden, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 151
  • Table 68: Microbiology Analyzers, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 153
  • Table 69: Microbiology Analyzers, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 155
  • Table 70: Microbiology Culture, Sweden, Distribution Share by Revenue ($m), USD Constant, 2010-2011 156
  • Table 71: Microbiology Culture, Sweden, Company Share by Revenue ($m), USD Constant, 2010-2011 158
  • Table 72: Clinical Chemisty Market Pipeline Products 174
  • Table 73: Immuno Chemistry Market Pipeline Products 178
  • Table 74: Haematology Market Pipeline Products 189
  • Table 75: Infectious Immunology Market Pipeline Products 191
  • Table 76: Microbiology Culture Market Pipeline Products 198
  • Table 77: Histology And Cytology Market Pipeline Products 199
  • Table 78: Genetic Testing Market Pipeline Products 200
  • Table 79: Trinity Biotech To Acquire Fiomi Diagnostics From Alfven & Didrikson For $13.1 Million 205
  • Table 80: Addtech Life Science Acquires Reagent And Instrument Firm, BioNordika Group 207
  • Table 81: bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 208
  • Table 82: Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System 210
  • Table 83: Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 211
  • Table 84: BioDot Enters Into Co-Marketing Agreement With JOT Automation 212
  • Table 85: BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays 213
  • Table 86: Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test 214
  • Table 87: Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology 216
  • Table 88: Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 217
  • Table 89: CML HealthCare Enters Into Agreement With MaRS Innovation 218
  • Table 90: Akrivis Technologies Enters Into Co-Development Agreement With United States Biological 219
  • Table 91: Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test 220
  • Table 92: Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products 221
  • Table 93: GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina 222
  • Table 94: Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test 223
  • Table 95: SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor 224
  • Table 96: Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 225
  • Table 97: MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test 226
  • Table 98: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus 228
  • Table 99: Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 230
  • Table 100: Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test 232
  • Table 101: One Lambda Enters Into Co-Marketing Agreement With CellTrend 233
  • Table 102: Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker 234
  • Table 103: Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 235
  • Table 104: Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel 236
  • Table 105: Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker 237
  • Table 106: Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology 238
  • Table 107: Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 239
  • Table 108: Opko Health Enters Into Licensing Agreement With International Health Technology For Prostate Cancer Biomarker Panel 240
  • Table 109: ZyGem Enters Into Co-Marketing Agreement With Tataa Biocenter 241
  • Table 110: Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit 242
  • Table 111: Denator Enters Into Co-Development Agreement With Erasmus And Amsterdam Medical For Cancer Biomarker Platform 243
  • Table 112: Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 244
  • Table 113: Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For Pressure Cycling Technology 245
  • Table 114: LipoScience Enters Into Licensing Agreement With Cleveland Clinic 247
  • Table 115: GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System 248
  • Table 116: NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers 249
  • Table 117: Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 250
  • Table 118: Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay For Sepsis 251

List of Figures

1.2 List of Figures

  • Figure 1: In Vitro Diagnostics, Market Segmentation 17
  • Figure 2: In Vitro Diagnostics, Sweden, Overall Revenue ($m), USD Constant, 2004-2018 18
  • Figure 3: In Vitro Diagnostics Market, Sweden, Revenue Mix ($m), 2011 20
  • Figure 4: In Vitro Diagnostics Market, Sweden, Category Contribution (%), 2011 21
  • Figure 5: In Vitro Diagnostics Market, Sweden, Cross-Category Analysis, 2004-2018 22
  • Figure 6: In Vitro Diagnostics, Sweden, Overall Revenue ($m), USD Constant, Historic, 2004-2011 24
  • Figure 7: In Vitro Diagnostics, Sweden, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 26
  • Figure 8: In Vitro Diagnostics, Sweden, Company Share (%), 2011 28
  • Figure 9: Clinical Chemistry, Market Segmentation 30
  • Figure 10: Clinical Chemistry Market, Sweden, Revenue Mix ($m), 2011 31
  • Figure 11: Clinical Chemistry Market, Sweden, Segment Contribution (%), 2011 32
  • Figure 12: Clinical Chemistry, Sweden, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 33
  • Figure 13: Clinical Chemistry, Sweden, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 35
  • Figure 14: Clinical Chemisty Analyzers, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 37
  • Figure 15: Clinical Chemisty Analyzers, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 39
  • Figure 16: Urine Analysis, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 41
  • Figure 17: Urine Analysis, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 43
  • Figure 18: Clinical Chemistry, Sweden, Company Share (%), 2011 46
  • Figure 19: Genetic Testing, Market Segmentation 48
  • Figure 20: Genetic Testing Market, Sweden, Revenue Mix ($m), 2011 49
  • Figure 21: Genetic Testing Market, Sweden, Segment Contribution (%), 2011 50
  • Figure 22: Genetic Testing, Sweden, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 51
  • Figure 23: Genetic Testing, Sweden, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 53
  • Figure 24: Genetic Testing, Sweden, Company Share (%), 2011 56
  • Figure 25: Haematology Market, Market Segmentation 58
  • Figure 26: Haematology Market, Sweden, Revenue Mix ($m), 2011 59
  • Figure 27: Haematology Market, Sweden, Segment Contribution (%), 2011 60
  • Figure 28: Haematology, Sweden, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 61
  • Figure 29: Haematology, Sweden, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 63
  • Figure 30: Haematology Reagents, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 65
  • Figure 31: Haematology Reagents, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 67
  • Figure 32: Immunohaematology, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 69
  • Figure 33: Immunohaematology, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 71
  • Figure 34: Haemostasis, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 73
  • Figure 35: Haemostasis, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 75
  • Figure 36: Haematology Rapid Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 77
  • Figure 37: Haematology Rapid Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 79
  • Figure 38: Haematology Cell Counters, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 81
  • Figure 39: Haematology Cell Counters, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 83
  • Figure 40: Haematology, Sweden, Company Share (%), 2011 86
  • Figure 41: Histology and Cytology Market, Market Segmentation 88
  • Figure 42: Histology And Cytology Market, Sweden, Revenue Mix ($m), 2011 89
  • Figure 43: Histology And Cytology Market, Sweden, Segment Contribution (%), 2011 90
  • Figure 44: Histology And Cytology, Sweden, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 91
  • Figure 45: Histology And Cytology, Sweden, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 93
  • Figure 46: Histology And Cytology, Sweden, Company Share (%), 2011 96
  • Figure 47: Immuno Chemistry Market, Sweden, Revenue Mix ($m), 2011 98
  • Figure 48: Immuno Chemistry Market, Sweden, Segment Contribution (%), 2011 99
  • Figure 49: Immuno Chemistry, Sweden, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 100
  • Figure 50: Immuno Chemistry, Sweden, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 102
  • Figure 51: Disease Specific Immunochemistry, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 104
  • Figure 52: Disease Specific Immunochemistry, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 106
  • Figure 53: Drugs of Abuse / Toxicology, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 108
  • Figure 54: Drugs of Abuse / Toxicology, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 110
  • Figure 55: Endocrinology Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 112
  • Figure 56: Endocrinology Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 114
  • Figure 57: Immunochemistry Rapid Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 116
  • Figure 58: Immunochemistry Rapid Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 118
  • Figure 59: Therapeutic Drug Monitoring, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 120
  • Figure 60: Therapeutic Drug Monitoring, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 122
  • Figure 61: Immunochemistry Analyzers, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 124
  • Figure 62: Immunochemistry Analyzers, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 126
  • Figure 63: Immuno Chemistry, Sweden, Company Share (%), 2011 129
  • Figure 64: Infectious Immunology, Market Segmentation 131
  • Figure 65: Infectious Immunology Market, Sweden, Revenue Mix ($m), 2011 132
  • Figure 66: Infectious Immunology Market, Sweden, Segment Contribution (%), 2011 133
  • Figure 67: Infectious Immunology, Sweden, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 134
  • Figure 68: Infectious Immunology, Sweden, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 136
  • Figure 69: Infectious Immunology Rapid Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 138
  • Figure 70: Infectious Immunology Rapid Tests, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 140
  • Figure 71: Infectious Immunology, Sweden, Company Share (%), 2011 143
  • Figure 72: Microbiology Culture, Market Segmentation 145
  • Figure 73: Microbiology Culture Market, Sweden, Revenue Mix ($m), 2011 146
  • Figure 74: Microbiology Culture Market, Sweden, Segment Contribution (%), 2011 147
  • Figure 75: Microbiology Culture, Sweden, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 148
  • Figure 76: Microbiology Culture, Sweden, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 150
  • Figure 77: Microbiology Analyzers, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 152
  • Figure 78: Microbiology Analyzers, Sweden, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 154
  • Figure 79: Microbiology Culture, Sweden, Company Share (%), 2011 157
  • Figure 80: F. Hoffmann-La Roche Ltd., Company Share (%),Sweden In Vitro Diagnostics Market, 2011 159
  • Figure 81: Siemens Healthcare, Company Share (%),Sweden In Vitro Diagnostics Market, 2011 160
  • Figure 82: Abbott Laboratories, Company Share (%),Sweden In Vitro Diagnostics Market, 2011 161
  • Figure 83: bioMerieux S.A., Company Share (%),Sweden In Vitro Diagnostics Market, 2011 162
  • Figure 84: Ortho-Clinical Diagnostics Inc., Company Share (%),Sweden In Vitro Diagnostics Market, 2011 163
  • Figure 85: Beckman Coulter, Inc., Company Share (%),Sweden In Vitro Diagnostics Market, 2011 164

Sweden In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture published by GlobalData in December 28, 2012. This report consists of Pages: 269 and the price starts from US $ 2500.

The contents of this page may be different from the latest version. Please contact us for details.
Back to Top